BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 24021866)

  • 21. SH3 domain ligand binding: What's the consensus and where's the specificity?
    Saksela K; Permi P
    FEBS Lett; 2012 Aug; 586(17):2609-14. PubMed ID: 22710157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
    McDonald CB; Seldeen KL; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
    Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
    J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
    Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.
    Schmidt H; Hoffmann S; Tran T; Stoldt M; Stangler T; Wiesehan K; Willbold D
    J Mol Biol; 2007 Feb; 365(5):1517-32. PubMed ID: 17141806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of the SH3 Domain Specificity Landscape in Yeasts.
    Verschueren E; Spiess M; Gkourtsa A; Avula T; Landgraf C; Mancilla VT; Huber A; Volkmer R; Winsor B; Serrano L; Hochstenbach F; Distel B
    PLoS One; 2015; 10(6):e0129229. PubMed ID: 26068101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward quantitative characterization of the binding profile between the human amphiphysin-1 SH3 domain and its peptide ligands.
    He P; Wu W; Wang HD; Yang K; Liao KL; Zhang W
    Amino Acids; 2010 Apr; 38(4):1209-18. PubMed ID: 19669081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
    Batra-Safferling R; Granzin J; Mödder S; Hoffmann S; Willbold D
    Biol Chem; 2010 Jan; 391(1):33-42. PubMed ID: 19919182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential ligand recognition by the Src and phosphatidylinositol 3-kinase Src homology 3 domains: circular dichroism and ultraviolet resonance Raman studies.
    Okishio N; Tanaka T; Fukuda R; Nagai M
    Biochemistry; 2003 Jan; 42(1):208-16. PubMed ID: 12515556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
    Kim J; Lee CD; Rath A; Davidson AR
    J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
    Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
    J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
    Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
    Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
    Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and structural characterization of an independently folding substructure in the src SH3 domain.
    Yi Q; Bystroff C; Rajagopal P; Klevit RE; Baker D
    J Mol Biol; 1998; 283(1):293-300. PubMed ID: 9761691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis of the recognition of the SAMP motif of adenomatous polyposis coli by the Src-homology 3 domain.
    Kaieda S; Matsui C; Mimori-Kiyosue Y; Ikegami T
    Biochemistry; 2010 Jun; 49(25):5143-53. PubMed ID: 20509626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
    Chan DC; Bedford MT; Leder P
    EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.